Category: Biotechnology
Biotechnology market research reports by DelveInsight
-
RNA Interference Therapy-Competitive landscape, 2023
RNA Interference Therapy-Competitive landscape, 2023 DelveInsight’s, “RNA Interference Therapy - Competitive landscape, 2023,” report provides comprehensive insights about 40+ companies and 90+ drugs in RNA Interference Therapy Competitive landscape. It covers the therapeutics assessment by product ... Read More
-
Bispecific antibody - Competitive landscape, 2023
Bispecific antibody - Competitive landscape, 2023 DelveInsight’s, “Bispecific antibody - Competitive landscape, 2023,” report provides comprehensive insights about 250+ companies and 300+ drugs in Bispecific antibody Competitive landscape. It covers the therapeutics assessment by product type, stage ... Read More
-
Gene Therapy-Competitive landscape, 2023
Gene Therapy-Competitive landscape, 2023 DelveInsight’s, “Gene Therapy - Competitive landscape, 2023,” report provides comprehensive insights about 250+ companies and 300+ drugs in Gene Therapy Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administrat ... Read More
-
CAR T - Cell Therapy- Competitive landscape, 2023
CAR T - Cell Therapy- Competitive landscape, 2023 DelveInsight’s, “CAR T - Cell Therapy- Competitive landscape, 2023,” report provides comprehensive insights about 250+ companies and 500+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product type, stag ... Read More
-
Anti-neutrophilic cytoplasmic antibody (ANCA) associated Vasculitis - Epidemiology Forecast - 2032
Anti-neutrophilic cytoplasmic antibody (ANCA) associated Vasculitis - Epidemiology Forecast - 2032 Key Highlights Anti-neutrophilic cytoplasmic antibody (ANCA) associated vasculitis is a heterogeneous group of rare autoimmune conditions. ANCA Associated Vasculitis includes three main diseases, which ... Read More
-
mRNA Vaccine and Therapeutics- Market Insights, Competitive Landscape, and Market Forecast - 2027
mRNA Vaccine and Therapeutics- Market Insights, Competitive Landscape, and Market Forecast - 2027 mRNA Vaccines And Therapeutics Market By Vaccine Type (Self-Amplifying Mrna Based Vaccines And Conventional Non-Amplifying mRNA Based Vaccines), By End-User (Hospitals And Clinics, Research And Developm ... Read More
-
COVID-19- Competitive Landscape, 2023
COVID-19- Competitive Landscape, 2023 DelveInsight’s, “COVID-19 - Competitive landscape, 2023,” report provides comprehensive insights about 400+ companies and 500+ drugs in COVID-19 Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and mol ... Read More
-
Microbiome- Competitive landscape, 2023
Microbiome- Competitive landscape, 2023 DelveInsight’s, “Microbiome- Competitive landscape, 2023,” report provides comprehensive insights about 130+ companies and 180+ drugs in Microbiome Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, an ... Read More
-
Antibody–drug Conjugates (ADCs) in Oncology- Competitive Landscape - 2023
Antibody–drug Conjugates (ADCs) in Oncology- Competitive Landscape - 2023 DelveInsight’s “Antibody–drug Conjugates (ADCs) Competitive landscape, 2023” report provides comprehensive insights about 30+ companies and 35+ drugs in ADCs. It covers the therapeutics assessment by product type, stage, route ... Read More
-
Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2023
Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2023 DelveInsight’s, “Angioimmunoblastic T cell Lymphoma – Pipeline Insight, 2023,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Angioimmunoblastic T cell Lymphoma pipeline landscape. It covers the pipelin ... Read More
-
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2023
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2023 DelveInsight’s, “Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2023” report provides comprehensive insights about 22+ companies and 24+ pipeline drugs in Phosphatidylinositol 3-Kinase (PI3K) Inhibitors pipel ... Read More
-
Drug Discovery - Market Insights, Competitive Landscape, and Market Forecast - 2027
Drug Discovery - Market Insights, Competitive Landscape, and Market Forecast - 2027 Drug Discovery Market By Workflow (Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, And Others), By Drug Type (Smal ... Read More
-
Bone Cement- Market Insights, Competitive Landscape, and Market Forecast - 2027
Bone Cement- Market Insights, Competitive Landscape, and Market Forecast - 2027 Bone Cement Market By Product Type (Polymethyl Methacrylate Cement, Glass Polyalkenoate Cement, And Calcium Phosphate Cement), By Joints (Knee, Hip, Shoulder, Spinal, And Others), By Procedure Type (Arthroplasty, Kyphopl ... Read More
-
Electrophoresis- Market Insights, Competitive Landscape, and Market Forecast - 2027
Electrophoresis- Market Insights, Competitive Landscape, and Market Forecast - 2027 Electrophoresis Market By Type (DNA Electrophoresis, RNA Electrophoresis, And Protein Electrophoresis), By Product (Gel Electrophoresis, Capillary Electrophoresis, Reagents & Consumables, And Others), By Application ... Read More
-
Polycythemia Vera Market Insight, Epidemiology and Market Forecast -2032
Polycythemia Vera Market Insight, Epidemiology and Market Forecast -2032 Key Highlights: In 2022, the market size of Polycythemia Vera was highest in the US among the 7MM accounting for approximately USD 1,500 million that is further expected to increase by 2032 PharmaEssentia’s Besremi is the only ... Read More
-
HUMIRA Market Drug Insight and Market Forecast − 2032
HUMIRA Market Drug Insight and Market Forecast − 2032 “HUMIRA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about HUMIRA for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the HUMIRA for ulcerative colitis in the 7MM, i.e., United S ... Read More
-
Birtamimab Emerging Drug Insight and Market Forecast – 2032
Birtamimab Emerging Drug Insight and Market Forecast – 2032 “Birtamimab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Birtamimab for AL Amyloidosis in the 7MM. A detailed picture of the Birtamimab for AL Amyloidosis in the 7MM, i.e., United States, EU ... Read More
-
Enzyme Linked Immunosorbent Assay (Elisa) Market Insights, Competitive Landscape and, Market Forecast - 2027
Enzyme Linked Immunosorbent Assay (Elisa) Market Insights, Competitive Landscape and, Market Forecast - 2027 ELISA MARKET BY PRODUCT TYPE (KITS AND REAGENTS, ELISA SYSTEMS, AND OTHERS), BY APPLICATION (HIV, PREGNANCY TESTING, COVID-19, AND OTHERS), BY END-USER (HOSPITALS AND DIAGNOSTIC LABS, PHARMAC ... Read More
-
Molecular Modeling Market Insights, Competitive Landscape and, Market Forecast - 2027
Molecular Modeling Market Insights, Competitive Landscape and, Market Forecast - 2027 MOLECULAR MODELING MARKET BY PRODUCT TYPE (SOFTWARE AND SERVICES), BY END-USER (BIOTECH AND PHARMACEUTICAL INDUSTRIES, RESEARCH ORGANISATIONS, AND OTHERS), BY GEOGRAPHY IS ESTIMATED TO REGISTER GROWTH AT A REMARKAB ... Read More
-
RNA- Competitive Landscape, 2022
RNA- Competitive Landscape, 2022 DelveInsight’s, “RNA- Competitive landscape, 2022,” report provides comprehensive insights about 85+ companies and 100+ drugs in RNA Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It fu ... Read More
-
COVID-19- Competitive Landscape, 2022
COVID-19- Competitive Landscape, 2022 DelveInsight’s, “COVID-19- Competitive landscape, 2022,” report provides comprehensive insights about 420+ companies and 520+ drugs in Covid-19 Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and mole ... Read More
-
TIGIT Inhibitors - Competitive Landscape, 2022
TIGIT Inhibitors - Competitive Landscape, 2022 DelveInsight’s, “TIGIT inhibitors - Competitive landscape, 2022,” report provides comprehensive insights about 18+ companies and 20+ drugs in TIGIT inhibitors Competitive landscape. It covers the therapeutics assessment by product type, stage, route of ... Read More
-
Gene Therapy - Competitive Landscape, 2022
Gene Therapy - Competitive Landscape, 2022 DelveInsight’s, “Gene therapy - Competitive landscape, 2022,” report provides comprehensive insights about 250+ companies and 300+ drugs in Gene therapy Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administra ... Read More
-
Microbiome- Competitive Landscape, 2022
Microbiome- Competitive Landscape, 2022 DelveInsight’s, Microbiome - Competitive landscape, 2022,” report provides comprehensive insights about 130+ companies and 200+ drugs in Microbiome Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, a ... Read More
-
CAR T - Cell Therapy - Competitive Landscape, 2022
CAR T - Cell Therapy - Competitive Landscape, 2022 DelveInsight’s, “CAR T - Cell Therapy - Competitive landscape, 2022,” report provides comprehensive insights about 193+ companies and 450+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product type, st ... Read More